VICR Community Comments: IP, Litigation, and Royalty Reality Check
Summary
Vicor's IP and royalty thesis is credible, but narrower than the most bullish community commentary suggests.
Supported: AI accelerators are making last-inch power delivery more important; Vicor owns differentiated architecture and packaging IP; it has successfully enforced two patents at the ITC; and royalty revenue is now material and growing.
Not established: universal protection against competing designs, victory in the pending 2026 case, the identity of unnamed licensees or customers, and community estimates of hundreds of millions or billions of dollars of near-term royalties.
>
Bottom line: Vicor has commercially validated, stronger-than-average IP protection—not an impregnable monopoly. Its royalties are recurring in part, but Q2 2026 should not yet be treated as a durable quarterly run rate.
Community claim check
| Bullish claim | Assessment |
|---|
| Increasing AI processor current makes VPD and last-inch power delivery more valuable | Directionally supported. The engineering problem is real, and Vicor's architecture addresses interconnect resistance and board losses. Company performance claims do not prove VPD will become the industry standard. |
| Vicor has defensible IP | Strongly supported, with limits. Vicor held 128 issued U.S. patents at year-end 2025. More importantly, it won an ITC violation finding and import remedies covering the `’481` and `’761` patents. |
| The first ITC case proves competitors cannot design around Vicor | Not supported. Some Delta products did not infringe the `’481` patent, and the ITC found no violation involving the `’950` patent. Redesigns and licensed implementations can fall outside the remedy. |
| The new 2026 ITC case confirms another broad monopoly | Premature. Investigation 337-TA-1484 has been instituted, but the ITC has made no merits determination. |
| The royalty stream is real and scalable | Supported. Vicor says royalties are generally calculated as a percentage of licensee sales. Revenue rose from $15.9M in 2023 to $57.4M in 2025 and reached $45.4M in H1 2026. |
| Q2 2026's $30.4M of royalties is a recurring base | Unproven. A new license drove the increase, but Vicor has not disclosed the licensee, rate, term, covered products, or whether Q2 included minimum, catch-up, or payment-based revenue. |
| The $45M 2025 legal settlement is recurring royalty revenue | No. Vicor reports it separately from revenue, and no continuing royalty was disclosed. |
| Google, AMD, or NVIDIA is the unnamed customer/licensee | Unconfirmed. Public filings do not identify them or validate community estimates of timing and economics. |
Litigation and IP strength
Evidence supporting the moat
In ITC investigation
337-TA-1370, Vicor established a Section 337 violation involving Patents
9,166,481 and
9,516,761. The ITC issued a limited exclusion order against covered unlicensed imports and cease-and-desist orders against several respondents. Vicor also satisfied the ITC domestic-industry requirements for those two patents.
Delta sought inter partes review of the `’481`, `’761`, and `’950` patents. The PTAB denied institution after finding that the petitions did not show the required likelihood of success on the claims remaining at issue. That is meaningful evidence of resilience, although not a universal validity judgment covering Vicor's entire portfolio.
Boundaries and adverse evidence
The first ITC result was mixed. Certain products did not infringe, the `’950` patent produced no violation, and some respondents possessed a license to the `’761` patent.
The current
337-TA-1484 case concerning Patent
12,395,087 could expand the demonstrated perimeter of Vicor's protection. For now it remains a pending allegation.
Enforcement also runs both ways. After losing separate SynQor litigation, Vicor paid
$28.6M in March 2026. That does not invalidate Vicor's patents, but it demonstrates overlapping patent estates and meaningful litigation costs.
Are royalties recurring?
Vicor's normal royalty model has recurring characteristics: royalties are generally a percentage of licensee sales and are recognized as covered sales or usage occurs.
| Period | Royalty revenue |
|---|
| 2023 | $15.9M |
| 2024 | $46.6M |
| 2025 | $57.4M |
| Q1 2026 | $15.0M |
| Q2 2026 | $30.4M |
| H1 2026 | $45.4M |
However, some licenses use minimum expected payments or recognize revenue upon payment. Reported royalty revenue may therefore combine recurring usage, minimums, catch-up amounts, and timing effects.
The attractive long-term outcome is a protected ecosystem in which Vicor earns high-incremental-margin royalties from second sources while also selling its own products. The principal risks are contract opacity, licensee concentration, design-arounds, patent expiration, and licensing economics that displace product revenue.
Conclusion
The record supports underwriting Vicor's existing royalty base and the two adjudicated patents. It does not support assuming success in the new litigation, naming undisclosed hyperscaler customers, or capitalizing Q2 royalties as a permanent annuity.
The next useful proof points are Q3–Q4 royalty persistence, disclosure about the new license's economic structure, progress in 337-TA-1484, and evidence that VPD is moving into repeatable high-volume accelerator platforms.
Primary sources